196 related articles for article (PubMed ID: 23239818)
1. Immune response evaluation through determination of type 1, type 2, and type 17 patterns in patients with epithelial ovarian cancer.
Cândido EB; Silva LM; Carvalho AT; Lamaita RM; Filho RM; Cota BD; da Silva-Filho AL
Reprod Sci; 2013 Jul; 20(7):828-37. PubMed ID: 23239818
[TBL] [Abstract][Full Text] [Related]
2. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
[TBL] [Abstract][Full Text] [Related]
3. Th1/Th2 CD4+ T cell responses against NY-ESO-1 in HLA-DPB1*0401/0402 patients with epithelial ovarian cancer.
Qian F; Gnjatic S; Jäger E; Santiago D; Jungbluth A; Grande C; Schneider S; Keitz B; Driscoll D; Ritter G; Lele S; Sood A; Old LJ; Odunsi K
Cancer Immun; 2004 Nov; 4():12. PubMed ID: 15521719
[TBL] [Abstract][Full Text] [Related]
4. Elevated Th22 cells and related cytokines in patients with epithelial ovarian cancer.
Wang T; Zhang Z; Xing H; Wang L; Zhang G; Yu N; Wang J; Guo W; Jiang J
Medicine (Baltimore); 2017 Oct; 96(43):e8359. PubMed ID: 29069020
[TBL] [Abstract][Full Text] [Related]
5. Sub-optimal primary surgery leads to unfavorable immunological changes in ovarian cancer patients.
Nowak M; Głowacka E; Lewkowicz P; Banasik M; Szyłło K; Zimna K; Bednarska K; Klink M
Immunobiology; 2018 Jan; 223(1):1-7. PubMed ID: 29017822
[TBL] [Abstract][Full Text] [Related]
6. Plasma immune analytes in patients with epithelial ovarian cancer.
Block MS; Maurer MJ; Goergen K; Kalli KR; Erskine CL; Behrens MD; Oberg AL; Knutson KL
Cytokine; 2015 May; 73(1):108-13. PubMed ID: 25743245
[TBL] [Abstract][Full Text] [Related]
7. Cytokine analysis as a tool to understand tumour-host interaction in ovarian cancer.
Yigit R; Figdor CG; Zusterzeel PL; Pots JM; Torensma R; Massuger LF
Eur J Cancer; 2011 Aug; 47(12):1883-9. PubMed ID: 21514148
[TBL] [Abstract][Full Text] [Related]
8. Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer.
Kolomeyevskaya N; Eng KH; Khan AN; Grzankowski KS; Singel KL; Moysich K; Segal BH
Gynecol Oncol; 2015 Aug; 138(2):352-7. PubMed ID: 26001328
[TBL] [Abstract][Full Text] [Related]
9. Does vitamin D mediate inhibition of epithelial ovarian cancer by modulating cytokines?
Mohapatra S; Saxena A; Gandhi G; Koner BC; Singh T; Ray PC
Clin Transl Oncol; 2015 Aug; 17(8):590-5. PubMed ID: 25740667
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of immune inhibitory cytokine profiles in epithelial ovarian carcinoma.
Chen LL; Ye F; Lü WG; Yu Y; Chen HZ; Xie X
J Obstet Gynaecol Res; 2009 Apr; 35(2):212-8. PubMed ID: 19335794
[TBL] [Abstract][Full Text] [Related]
11. Th1 and Th17 Predominance in the Enthesitis-related Arthritis Form of Juvenile Idiopathic Arthritis.
Mahendra A; Misra R; Aggarwal A
J Rheumatol; 2009 Aug; 36(8):1730-6. PubMed ID: 19531753
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Th17 lymphocytes and cytokine IL‑17A in epithelial ovarian tumors.
Winkler I; Pyszniak M; Pogoda K; Semczuk A; Gogacz M; Miotla P; Adamiak A; Darmochwal-Kolarz D; Rechberger T; Tabarkiewicz J
Oncol Rep; 2017 May; 37(5):3107-3115. PubMed ID: 28393233
[TBL] [Abstract][Full Text] [Related]
13. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
14. Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients.
Dalal V; Kumar R; Kumar S; Sharma A; Kumar L; Sharma JB; Roy KK; Singh N; Vanamail P
Clin Chim Acta; 2018 Jul; 482():27-32. PubMed ID: 29572186
[TBL] [Abstract][Full Text] [Related]
15. Natural Killer Cells Response to IL-2 Stimulation Is Distinct between Ascites with the Presence or Absence of Malignant Cells in Ovarian Cancer Patients.
da Silva RF; Yoshida A; Cardozo DM; Jales RM; Paust S; Derchain S; Guimarães F
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513532
[TBL] [Abstract][Full Text] [Related]
16. Changes in the Ratio of T Helper 1 to T Helper 2 Signature Cytokines in Patients Undergoing Living Donor Liver Transplantation Surgery: A Prospective Controlled Study.
Lee HM; Ghill BK; Park E; Park CY; Choi WK; Lee J
Transplant Proc; 2018 Dec; 50(10):3621-3625. PubMed ID: 30577247
[TBL] [Abstract][Full Text] [Related]
17. [Changes of Th1/Th2/Th17 in patients received non-myeloablative haploidentical hematopoietic stem cell transplantation detected by flow cytometric bead array].
Zhao YY; Kang Y; Sun QY; Dong Z; Liu TQ; Liu GX; Guo M; Ai HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):431-5. PubMed ID: 23628048
[TBL] [Abstract][Full Text] [Related]
18. Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer.
Zhu Q; Wu X; Wu Y; Wang X
Oncol Rep; 2016 Dec; 36(6):3472-3478. PubMed ID: 27748885
[TBL] [Abstract][Full Text] [Related]
19. TNF-α inhibitors reduce the pathological Th
Campanati A; Orciani M; Lazzarini R; Ganzetti G; Consales V; Sorgentoni G; Di Primio R; Offidani A
Exp Dermatol; 2017 Apr; 26(4):319-324. PubMed ID: 27376466
[TBL] [Abstract][Full Text] [Related]
20. The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications.
Waśkiel-Burnat A; Osińska M; Salińska A; Blicharz L; Goldust M; Olszewska M; Rudnicka L
Cells; 2021 Dec; 10(12):. PubMed ID: 34943905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
